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in international public health. This is achieved through: specialized surveil-
lance networks; outbreak verification.
The World Health Organization (WHO) recognizes the importance ofin
partners in global epidemic surveillance and seeks to identify more effective
ways of working with collaborating institutions. To this end the WHO
global epidemic surveillance team links with a number of international
networks for specific disease threats.
To investigate and follow up outbreak reports, an innovative mechanism
_outbreak verification - was established at WHO headquarters in early 1997.
Its aim is to improve epidemic disease control by actively collecting and
verifying information on reported outbreaks and informing key public
health professionals of confirmed and unconfirmed outbreaks which are
potentially ofinternational public health importance. Outbreaks are assessed
for their importance to international public health (an outbreak with
potential for international spread, a need for international response, or a
potential impact on international travel or trade). Active follow-up with
affected countries is undertaken to verify the existence of the epidemic, its
cause and the response being put in place. WHO offers assistance in all cases.
525 - Pathogenicity islands and other horizontal. , .
[WeS11 1How do we protect ourselves against an outbreak of
hemorrhagic fever
A. Vaheri
Department of Virology, Haartman Institute, University of Helsinki, Finland
Viral hemorrhagic fevers (VHFs) are caused by arenaviruses (Lassa fever,
South American HFs), filoviruses (Ebola, Marburg), bunyaviruses (Crim-
ean-Congo HF, HFRS, Rift Valley fever) and ftaviviruses (dengue HF,
yellow fever). VHFs are zoonoses, prime examples of emerging infectious
diseases, several with dramatic clinical course and high mortality. Only
CGHF and hantaviral HFRSs have known animal reservoirs in Europe but
VHFs may be acquired abroad or, very rarely, in a laboratory setting, or
from an imported animal. The dramatic nature of VHF outbreaks easily
generates excessive media attention. Some VHFs are considered potential
weapons of bioterrorism. Thus there is increasing awareness to develop
better means to manage and control VHFs. Much can be done. (i) National
guidelines. Here we should remember that person-to-person spread ofVHFs
requires direct contact (blood, excreta) and that ribavirin is effective against
several VHFs. (ii) Effective channels of communication. Internet services
currently include WHO Outbreak Verification List, ProMed, and Euro-
Surveillance; specialized net on-line journals such as "Emerging Infectious
Diseases" arc also useful. (iii) Increased preparedness for rapid diagnostics
and international outbreak response (task force). In the multinational
Europe, unlike at CDC in the US, the diagnostic facilities are still limited.
While both rapid and safe tests (PCR, strip tests) as well as reliable reference
tests and BSL-4 laboratories arc needed, the first thing to suspect is still
malaria. The "European Network for Diagnostics of Imported Viral
Diseases" has built a network of European laboratories working on diag-
nostics of imported, rare, and emerging viral infections.
IWeS131 Pathogenicity islands of gram-negative bacteria:
Functional and evolutionary aspects
J. Heesemann
Max von Pettenkofer-lnstitut, Munith, Germany
In the early years of Medical Microbiology pathogenic bacteria were
characterized phenotypically by one virulence factor (e.g. toxin). Later,
the high complexity and variability ofpathogenic bacteria became evident.
In analogy to evolution of antibiotic resistance, transposons, plasmids,
phages and large mobile chromosomally integrated units (phathogenicity
islands, PAl) have been identified as carriers of pathogenicity genes and
virulons. Human pathogenic and opportunistic Gram-negative bacteria are
frequently carriers of PAIs. A complete PAl is ftanked by short directed
repeats and carries genes for PAl mobility (e.g. integrase). Many PAIs consist
of several modules which encode for type III secretion systems, several
antihost effector proteins, adhesins, ferric iron uptake systems and carry
DNA regions ofphage or plasmid origin. Because oftheir mobility PAIs can
disseminate into diverse species and thus generate new pathotypes. For
Escherichia coli more than six PAIs have been identified. The PAl-pattern
determines the pathotype ofE. coli e.g. EHEC, EPEC. UTEC.lnterestingly,
the majority ofsttains isolated from blood culture or urine ofpatients carry
the PAl ofYersinia pestis (denoted as HPJ), In Salmonella enteriea SPI-l is
involved in intestinal invasion and SPI-2 in intracellular survival. The impact
of PaIs in evolution of Samonella, Yersinia and Escherichia coli will be
discussed.
IWeS14j Bacterial crosstalk: Interaction between Yerslnia and
its target cell
H. Wolf-Watz
Cell and Moletular Biology, Umea, Sweden Ullil'ersity
We are using Yersillia pseudotuberculosis as a model to understand the basic
mechanisms behind the cell-contact dependent induction and subsequent
polarized translocation of the effector proteins (Yops) into the cytosol of the
target cell. Y. pseudotuberculosis up-regulates Yop-expression after an inti-
mate contact between the pathogen and its target cell has been established.
This cross-talk involves also the Type III secretion machine. The transloca-
tion mechanism is polarized and is dependent on at least three proteins
Yopll, YopD and LcrV respectively. Our results suggest that the YopB.
YopD and LcrV are involved in forming a pore in the membrane of the
target cell. After translocation, the different Yop-effectors are targeted to
different regions of the eukaryotic cell. The protein-tyrosine phosphatase
YopH. showing high homology with eukaryotic PTPases. blocks immedi-
ate early phosphorylation signals after infection. YopH is targeted to
focaladhesions leading to disruption of these structures. YopE works in
concert with YopH and these two proteins are essential for the pathogen to
block phagocytosis. YopE possesses a GAP activity which inactivates
proteins of the Rho-family of small G-proteins leading to disruption of
cell's cytoskeleton.
[WeS151 Comparative and functional genomics of Neisseria
X. Nassif
INSERM U411, Fa(llite Necker-E,ifants Malades, Paris, Franu
Neisseria meningitidis (Nm), Neisseriagotlorrhoeae (Ng), and Neisseria lattamica
(NI) belong to the same genospecies. However, they express dramatically
different pathogenesis. Nm colonizes the nasopharynx and is responsible for
septicemia and meningitis, Ng gives rise to a localised infection, and NI has
never been associated to a disease and is therefore believed to be non
pathogenic. Considering that both Nm and Ng are human pathogens
which do not survive in the environment and which colonize and invade
mucosa at their port of entry, it is likely that they share common
characteristics which are not found in the non pathogenic Nl. Furthermore
N. meningitidis may express specific virulence factors responsible for the
bloodstream dissemination and the crossing ofthe blood brain barrier. These
properties of pathogenic Neisseria may be determined by specific chromo-
somal regions. To address this issue, we used a combination of both
subtractive hybridization and hybridization of DNA arrays to identify
chromosomal regions specific for Nm and common between Nm and
N.g. These experiments confirmed that Nm has specific chromosomal
regions and others which arc shared with Ng. An analysis of the content
of these regions as well as the consequences of the mutagenesis of some of
these regions will be presented and tested in several models believed to be
associated with virulence.
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1WeS20IHow to report susceptibility results to clinicians
R. Auckenthaler
University HospitalSu'itzerland
Susceptibility test determine the susceptibility ofbacteria against antibiotics.
They are necessary to detect acquired resistance. For the clinician the
development of resistance makes the adequate prescription of antibiotics
more difficult Historically susceptibility tests have been performed by disk
diffusion. Today they include disk diffusion, growth of bacteria at various
antibiotic concentration or direct determination of MIC. All methods
correlate presumed or calculated MIC to the in vivo activity, reporting
sensitive, intermediate or resistant strains predicting the likely probability of
clinical success. Susceptibility tests allow to 1) the adapted prescription of
antimicrobial agents for a precise pathogen, 2) to follow epidemiological
trends of resistance. useful for empirical therapy, 3) detection of multi-
resistant strains with risk of nosocomiJll dissemination.
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Microbiologist should use an optimal and cleat presentation for suscept-
ibility results. cumulative reporting. tracing of epidemiological strains and
adequate comments to optimally inform clinicians.
527 - New technologies and advances in the diagnosis .•.
[We5~ Alternatives to microscopic diagnosis of malaria
T. H:inscheid
Hospital Santa Maria, Lisbon. Portugal
Microscopy of Giemsa-stained thick and thin films remains the current
reference method to diagnose malaria. However. it is time-consuming.
requires expertise in microscopy and maintenance of equipment. In devel-
oping nations scarce resources lead to inadequate diagnostic procedures.
while in affluent countries poor familiarity with mabria may cause mis-
diagnosis. Several alternative tests have; been developed recentl~ Micro-
scopy with Ouorescent stains. including centrifugation (QBC ). show
sensitivities and specificities similar to conventional microscopy. although
much quicker to perform. However. they need spcL;al equipment and
training. especially in the differentiation of species. Dipstick anti~en-detec­
tion of parasite Histidine-Rich-Protein II (HRP II) (parasight '-F, ICT
Malaria®) Lactate dehydrogenase (OptiMAL®) or HRPII/AldoWe (ICT
Malaquick Pf/Pv®) are also quick to perform and do not need any
equipment. These tests show sensitivities and specificities comparable to
microscopy. although at lower parasitaemias sensitivities may decrease
significantly, and they detect only P. falciparum (parasightF~. ICT
Malaria®) or P. falciparum and vivax (OptiMAL®. ICT Malaquick Pf/
Pv®). These dipstick-tests may be useful in remote areas without laboratory
access or in laboratories as back-up to microscopy. e.g. for non-experts
during on-ca11s. Polymerase-chain-reaction assays are more sensitive and
specific than microscopy. however. they are oflimited value in the diagnosis
of acute malaria. Automated blood cell analysers (Cell-Dyn 3500®) are a
novel way to diagnose malaria during routine use for Full-Blood-Counts
and may have the potential to detect malaria cases. even in the absence of
clinical suspicion.
IWe522IVisceral leishmaniasis: New diagnostic approaches
L. Gradoni
Parasitology Dept., Istituto Superiore di Sanita, Rome, Italy
The standard technique for the diagnosis of first episodes and relapses of
visceral leishmaniasis (VL) is the bone marroW' aspirate microscopy and
culture, which results in > 95% sensitivity. However. this is an invasive
procedure which requires experienced microscopists and the availability of
freshly prepared culture media. New diagnostic approaches have been
proposed which. however. must be treated differently in the two cohorts
ofVl patients. i.e. HIV-negative and HIV-infected individuals.
VL in HIV-negative individuals - Antileishmanial antibodies are detected
in 99-100% ofthese patients by a number ofimmunological tests which use
Leishmania crude antigens. Recently. test specificity was greatly increased by
the use of recombinant antigens. Serology should represent the first and.
probably. the sole diagnostic approach in immunocompetent individuals.
Furthermore. serial titration of specific antibodies at 2-3 months intervals
has high prognostic utility in the follow-up of drug treated patients.
Vl in HIV-infected individuals - less than 60-70% ofthese patients have
detectable antileishmanial antibodies; however, 70-75% have parasites in
peripheral blood. Sensitive techniques have been developed to detect
microscopically Leishmania on leukocytoconcentrates, or to amplify leish-
manial DNA (PCR) from buffy-coat or blood-spot filter paper samples.
The use of these noninvasive techniques is of great value in the patient's
follow-up.
528 - Pathogenesis for gram-positive sepsis and shock
IWe524I Advances in the diagnosis of Toxoplasma infection
Babill Stray-Pedersen
Department ofGynecology and Obstetrics, National Hospital, Oslo, Norway
Toxoplasma infections are wide spread and occur all over Europe. The
infection is usually benign, but can induce severe complications ifit occurs in
a developing fetus or ~n immunocompromised patient.
Exposure to infection v~ri", region~lIy. From 30-90% of women are
non-immune and susceptible to infection. 0.5-5 women per 1000 acquire
the infection during pregnancy with ~n over all fetal transmission rate of
30%.
The diagnosis ofT. infection depends either on identification of parasites
in tissue/body Ouids or on detection ofspecific antibodies. In pregnancy the
diagnostic challenge lies in differentiating between primary maternal infec-
tion which may cause fctal infection and past latent infection which is without
importance. In the fetus and neon~te the challenge is to identify infected cases
at an early stage. while in patients with chorioretinitis or AIDS it is
important to decide if Toxoplasma is involved.
An arsenal of diagnostic assays is available for detection of Toxoplasma
specific antibodies. The EIA method is mostly used both for IgG. IgM and
IgA detection. The direct agglutination is suitable for screening, while
recently the IgG avidity test has proven useful in determining the time of
infection.
Thc PCR method has found its place in diagnosis offetal infection where
the presence ofToxoplasma DNA in amniotic Ouid indicatL"S maternal fetal
transmission.
In the HIV patient the antibody titers arc low or undetectable. A definite
diagnosis has to rely upon antigen detection. In ocular toxoplasmosis
dcmonstration of antibody production in aqueous humor may be helpful.
IWe525! Contact phase activation and bacterial virulence
L. Bjorck
Department ofCell arId Molecular Biology, Lund, Sweden
A starting point for our studies was the observation that high-molecular-
mass kininogen (H-kininogen) binds to the surface of several species of
pathogenic bacteria. H-kininogen is a multifunctional plasma protein which
together with the other components of the contact phase system, factor XI
and factor XII of the blood coagulation system and plasma prekallikrein.
participates in molecular events leading to the activation of the intrinsic
pathway ofblood coagulation, and to the release of bradykinin (BK) from
H-kininogen. BK is a nonapeptide and a primary mediator ofinftammation,
which through the induction ofsecondary mediators such as prostaglandins
and nitric oxide. induces pain. increased vascular permeability and v~sodi­
latation. It was demonstrated that interactions between contact phase factors
and bacterial surface proteins result in the release of BK ~t the site of
infection. Furthermore. an extracellular cysteine protein~se produced by
Streptococcus pyogenes induces a rapid breakdown of H-kininogen and
massive BK rele~se. Fin~lIy. ~bsorption of contact phase proteins and
fibrinogen by bacterial surface proteins causes a hypocoagulatory state.
These molecular mechanisms may contribute to the bleeding disorders and
the hypovolemic hypotension seen in patients with severe infections disease.
IWe526! The role of superantigens and bacterial DNA during
Lethal Shock
K. Heeg
Institute ofMedical Microbiology and Hygiem Philipps-University, Marburg,
Germany
Endotoxin (lPS) has been defined to playa major role during pathogenesis
of infection. Gram-positive bacteria do not contain LPS yet induce strong
responses of innate immune cells. At least two products or components of
gram-positive bacteria have been defined with similar effects. Once. super-
antigens like the staphylococcal enterotoxin B (SEB) activate oligoclonally
T-lymphocytes. This activation results in a burst of cytokine secretion that
can induce a lethal cytokine syndrome. Moreover, SEB induced interferon-
"'( (IFN-"'() modulates the status of macrophages and thus enhances their
response to lPS. Second, bacterial DNA derived from gram-positive or
gram-negative bacteria has been shown to be a potent activator of innate
immune cells. DNA mediated activation is DNA sequence dependent and
relies on the abundance of frcc CpG-dinucleotides which are less frequent
and methylated in mammalian DNA (CG-suppression). Recent studies have
shown, that even synthetic oligonucleotides (DON) displaying a certain
DNA motifs activate efficiently innate immune cells like macrophages or
dendritic cells. Bacteri~1 DNA and CpG-OON induce production of large
amounts of pro-inOammatory cytokines which can induce lethal shock.
However. epG-DNA also can be used to modulate ongoing immune
responses. This effect of CpG-DNA can be used to develop new adjuv:mts
which preferenti~lIy induce Thl-immune responses.
